Clinical trial
Mechanisms of Semaglutide Therapy in Heart Failure Patients
NCT06541509
Study timeline
Study start (actual)2024-07-10Date precision: day
Registry last updated2024-08-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Obesityunresolved
Interventions
SemaglutideDRUG · verified · RxNorm: semaglutide
Sponsors & collaborators
University Medical Centre Ljubljanalead sponsor
Stanford Universitycollaborator
Greenstone Biosciences, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06541509 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.